Current and Potential Treatments for Cervical Cancer | Bentham Science
Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Current and Potential Treatments for Cervical Cancer

Author(s): Grace P.C. Yee, Paul de Souza and Levon M. Khachigian

Volume 13, Issue 2, 2013

Page: [205 - 220] Pages: 16

DOI: 10.2174/1568009611313020009

Price: $65

Open Access Journals Promotions 2
Abstract

Cervical cancer is the third most common carcinoma in women worldwide. Despite increasing efforts to improve therapy in this disease, a significant proportion of women still die, mostly from recurrent or chemoresistant disease. This review discusses current treatments for early cervical cancer, advanced disease, and recurrent cervical cancer, and covers concurrent chemoradiation, neoadjuvant chemotherapy before surgery and radiation, single agent treatment, combination treatment, platinum-based and non-platinum based therapy. We also discuss promising therapeutic strategies for cervical cancer including targeted therapy, cell-based therapy, combined siRNA and chemotherapy, and immunotherapy.

Keywords: Cervical cancer, side-effects, targeted, therapy.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy